A data-driven framework for biomarker discovery applied to optimizing modern clinical and preclinical trials on Alzheimer’s disease
Isaac Llorente-Saguer, Neil P Oxtoby · 2024
Read A data-driven framework for biomarker discovery applied to optimizing modern clinical and preclinical trials on Alzheimer’s disease by Isaac Llorente-Saguer, Neil P Oxtoby (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11632366.txt.
Description
Isaac Llorente-Saguer and Neil Oxtoby present a framework for finding better biomarkers in Alzheimer disease in this 2024 paper. Scans that track tau protein in the brain are used to follow the disease, but picking which brain regions to compare in a scan ratio is a nontrivial choice.
Their framework, BioDisCVR, searches data for the pair of combined regions whose ratio gives the cleanest signal. It was tested on tau scans from 198 people in one database, with 42 more from Mayo Clinic cohorts as an outside check. Found biomarkers were judged by the trial size they would need, a direct measure of how useful they are for drug trials.
Catalog record
| CREATOR | Isaac Llorente-Saguer, Neil P Oxtoby |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |